The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopakâ„¢ ...
Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results